137 related articles for article (PubMed ID: 24707164)
1. Short-term intraocular pressure changes after intravitreal injection of bevacizumab in diabetic retinopathy patients.
Farhood QK; Twfeeq SM
Clin Ophthalmol; 2014; 8():599-604. PubMed ID: 24707164
[TBL] [Abstract][Full Text] [Related]
2. Short-term intraocular pressure changes after intravitreal injection of bevacizumab.
Hollands H; Wong J; Bruen R; Campbell RJ; Sharma S; Gale J
Can J Ophthalmol; 2007 Dec; 42(6):807-11. PubMed ID: 18026202
[TBL] [Abstract][Full Text] [Related]
3. Transient Intraocular Pressure Fluctuations After Intravitreal Bevacizumab Injection in Proliferative Diabetic Retinopathy Patients: A Prospective Study.
Luqman F; Bibi H; Mukhtar M; Zafar F; Ahmed H; Khizer MA; Gul N
Cureus; 2023 Sep; 15(9):e45371. PubMed ID: 37849604
[TBL] [Abstract][Full Text] [Related]
4. Short-term intraocular pressure changes after intravitreal injection of bevacizumab for retinopathy of prematurity.
Kato A; Okamoto Y; Okamoto F; Saito M; Miyazono Y; Oshika T
Jpn J Ophthalmol; 2019 May; 63(3):262-268. PubMed ID: 30825009
[TBL] [Abstract][Full Text] [Related]
5. Effect of prophylactic intraocular pressure-lowering medication on intraocular pressure spikes after intravitreal injections.
Frenkel MP; Haji SA; Frenkel RE
Arch Ophthalmol; 2010 Dec; 128(12):1523-7. PubMed ID: 21149773
[TBL] [Abstract][Full Text] [Related]
6. Intraocular Pressure Changes in Non-Glaucomatous Patients Receiving Intravitreal Anti-Vascular Endothelial Growth Factor Agents.
Kiddee W; Montriwet M
PLoS One; 2015; 10(9):e0137833. PubMed ID: 26360382
[TBL] [Abstract][Full Text] [Related]
7. Sustained elevation of intraocular pressure after intravitreal injections of bevacizumab in eyes with neovascular age-related macular degeneration.
Mathalone N; Arodi-Golan A; Sar S; Wolfson Y; Shalem M; Lavi I; Geyer O
Graefes Arch Clin Exp Ophthalmol; 2012 Oct; 250(10):1435-40. PubMed ID: 22434210
[TBL] [Abstract][Full Text] [Related]
8. Immediate Rise in Intraocular Pressure After First-Time Intravitreal Injection of Bevacizumab.
Mahar PS; Bukhari S; Shakeel A; Memon AS; Mahmood T
Cureus; 2023 May; 15(5):e38916. PubMed ID: 37313087
[TBL] [Abstract][Full Text] [Related]
9. Effect of prior glaucoma surgery on intraocular pressure immediately after anti-vascular endothelial growth factor injection.
Lam J; Luttrell I; Ding L; Rezaei K; Chao JR; Chee Y; Olmos De Koo LC; Wen JC
Graefes Arch Clin Exp Ophthalmol; 2019 Nov; 257(11):2489-2494. PubMed ID: 31388743
[TBL] [Abstract][Full Text] [Related]
10. Long-term intraocular pressure changes after intravitreal injection of bevacizumab.
Baek SU; Park IW; Suh W
Cutan Ocul Toxicol; 2016 Dec; 35(4):310-4. PubMed ID: 26820610
[TBL] [Abstract][Full Text] [Related]
11. Short-Term Changes in Intraocular Pressure After Intravitreal Injection of Bevacizumab for the Treatment of Retinopathy of Prematurity.
Obata S; Higashiyama T; Imamura T; Kakinoki M; Yanagi T; Maruo Y; Ohji M
Clin Ophthalmol; 2019; 13():2445-2449. PubMed ID: 31849442
[TBL] [Abstract][Full Text] [Related]
12. Immediate effect of intravitreal injection of bevacizumab on intraocular pressure.
Lemos-Reis R; Moreira-Gonçalves N; Melo AB; Carneiro AM; Falcão-Reis FM
Clin Ophthalmol; 2014; 8():1383-8. PubMed ID: 25092962
[TBL] [Abstract][Full Text] [Related]
13. Short-term effects and safety of an acute increase of intraocular pressure after intravitreal bevacizumab injection on corneal endothelial cells.
Park J; Lee M
BMC Ophthalmol; 2018 Jan; 18(1):17. PubMed ID: 29368595
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of short-term intraocular pressure changes after intravitreal injection of Conbercept in patients with diabetic macular edema.
Hu Y; Zeng Y; Yang J; Zeng X; Cao D; Ou B; Zhang G; Zhang L
Front Pharmacol; 2022; 13():1025205. PubMed ID: 36578537
[No Abstract] [Full Text] [Related]
15. Intraocular Pressure in Eyes Receiving Intravitreal Antivascular Endothelial Growth Factor Injections.
Lemos V; Cabugueira A; Noronha M; Abegão Pinto L; Reina M; Branco J; Gomes T
Ophthalmologica; 2015; 233(3-4):162-8. PubMed ID: 25791262
[TBL] [Abstract][Full Text] [Related]
16. Short-term course of intraocular pressure after intravitreal injection of triamcinolone acetonide.
Benz MS; Albini TA; Holz ER; Lakhanpal RR; Westfall AC; Iyer MN; Carvounis PE
Ophthalmology; 2006 Jul; 113(7):1174-8. PubMed ID: 16647122
[TBL] [Abstract][Full Text] [Related]
17. [Variations in intraocular pressure (IOP) and necessity for paracentesis following intravitreal triamcinolone injection].
Dwinger MC; Pieper-Bodeewes I; Eter N; Holz FG
Klin Monbl Augenheilkd; 2005 Aug; 222(8):638-42. PubMed ID: 16118744
[TBL] [Abstract][Full Text] [Related]
18. Effect of antiglaucoma agents on short-term intraocular pressure fluctuations after intravitreal bevacizumab injections.
Shoeibi N; Ghosi Z; Jafari H; Omidtabrizi A
Int Ophthalmol; 2021 Mar; 41(3):1081-1090. PubMed ID: 33389369
[TBL] [Abstract][Full Text] [Related]
19. Reduction of Intraocular Pressure Spikes Due to Intravitreal Bevacizumab Injections by Scleral Indentation with Cotton Swab or Digital Ocular Massage: Innovative Techniques Compared.
Nuzzi R; Scalabrin S; Becco A
Clin Ophthalmol; 2020; 14():2533-2541. PubMed ID: 32921980
[TBL] [Abstract][Full Text] [Related]
20. Sustained elevated intraocular pressures after intravitreal injection of bevacizumab, ranibizumab, and pegaptanib.
Choi DY; Ortube MC; McCannel CA; Sarraf D; Hubschman JP; McCannel TA; Gorin MB
Retina; 2011 Jun; 31(6):1028-35. PubMed ID: 21836409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
